Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Ovidiu C. Andronesi"'
Autor:
Maciej M. Mrugala, Edward A. Neuwelt, Heiko Schöder, Benjamin M. Ellingson, C. Chad Quarles, Gerald Illerhaus, Tracy T. Batchelor, Timothy J. Kaufmann, Andrés J.M. Ferreri, James L. Rubenstein, Christopher P. Fox, Nicoletta Anzalone, Christian Grommes, Leland S. Hu, Letterio S. Politi, Ovidiu C. Andronesi, Dorothee P. Auer, Jerrold L. Boxerman, Motoo Nagane, Ramon F. Barajas, Prakash Ambady
Publikováno v:
Neuro-Oncology
Neuro-oncology, vol 23, iss 7
Neuro-oncology, vol 23, iss 7
Advanced molecular and pathophysiologic characterization of primary central nervous system lymphoma (PCNSL) has revealed insights into promising targeted therapeutic approaches. Medical imaging plays a fundamental role in PCNSL diagnosis, staging, an
Autor:
Ovidiu C. Andronesi, Xianqi Li
Publikováno v:
Neuro Oncol
Metabolic imaging can map spatially abnormal molecular pathways with higher specificity for cancer compared to anatomical imaging. However, acquiring high resolution metabolic maps similar to anatomical MRI is challenging in patients due to low metab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6783d87ecf2631c6e806b2b74ccfb233
https://europepmc.org/articles/PMC8598587/
https://europepmc.org/articles/PMC8598587/
Autor:
Ulf Neuberger, Kourosh Jafari-Khouzani, Martin Bendszus, Jorg Dietrich, Xianqi Li, Ovidiu C. Andronesi, Daniel P. Cahill, Tracy T. Batchelor, Philipp Vollmuth, Bernhard Strasser
Publikováno v:
Neuro-oncology Advances
Metabolic imaging can map spatially abnormal molecular pathways with higher specificity for cancer compared to anatomical imaging. However, acquiring high resolution metabolic maps similar to anatomical MRI is challenging due to low metabolite concen
Publikováno v:
Glioma Imaging ISBN: 9783030273583
Recurrent heterozygous mutations of isocitrate dehydrogenase (IDH1 and IDH2) are primary genetic events in gliomagenesis and largely determine the subsequent evolution and clinical phenotype of this class of brain tumors. Mutations in the residues R1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b723cc59fc0405b4f799215ffce5f35
https://doi.org/10.1007/978-3-030-27359-0_11
https://doi.org/10.1007/978-3-030-27359-0_11
Publikováno v:
Cancer. 123:4535-4546
The metabolic genes isocitrate dehydrogenase 1 (IDH1) and IDH2 are commonly mutated in low-grade glioma and in a subset of glioblastoma. These mutations co-occur with other recurrent molecular alterations, including 1p/19q codeletions and tumor suppr
Autor:
Tracy T. Batchelor, Małgorzata Marjańska, A. John Iafrate, Daniel P. Cahill, Bruce R. Rosen, Andrew S. Chi, Franziska Loebel, Jorg Dietrich, Wolfgang Bogner, Elizabeth R. Gerstner, William G. Kaelin, Matthew G. Vander Heiden, Ovidiu C. Andronesi
Publikováno v:
PMC
Purpose: Measurements of objective response rates are critical to evaluate new glioma therapies. The hallmark metabolic alteration in gliomas with mutant isocitrate dehydrogenase (IDH) is the overproduction of oncometabolite 2-hydroxyglutarate (2HG),
Autor:
Eva-Maria Ratai, Zheng Zhang, James Fink, Mark Muzi, Lucy Hanna, Erin Greco, Todd Richards, Daniel Kim, Ovidiu C Andronesi, Akiva Mintz, Lale Kostakoglu, Melissa Prah, Benjamin Ellingson, Kathleen Schmainda, Gregory Sorensen, Daniel Barboriak, David Mankoff, Elizabeth R Gerstner, ACRIN 6684 trial group
Publikováno v:
PLoS ONE, Vol 13, Iss 6, p e0198548 (2018)
PloS one, vol 13, iss 6
PLoS ONE
PloS one, vol 13, iss 6
PLoS ONE
A multi-center imaging trial by the American College of Radiology Imaging Network (ACRIN) "A Multicenter, phase II assessment of tumor hypoxia in glioblastoma using 18F Fluoromisonidazole (FMISO) with PET and MRI (ACRIN 6684)", was conducted to asses
Autor:
Heisoog Kim, Ovidiu C. Andronesi, Rakesh K. Jain, A. Gregory Sorensen, Ciprian Catana, Eva-Maria Ratai, Tracy T. Batchelor, Dominique Jennings
Publikováno v:
Cancer Research. 71:3745-3752
Proton magnetic resonance spectroscopy is increasingly used in clinical studies of brain tumor to provide information about tissue metabolic profiles. In this study, we evaluated changes in the levels of metabolites predominant in recurrent glioblast
Publikováno v:
International Journal of Oncology
The non-essential amino acid neurotransmitter glycine (Gly) may serve as a biomarker for brain tumors. Using 36 biopsies from patients with brain tumors [12 glioblastoma multiforme (GBM); 10 low-grade (LG), including 7 schwannoma and 3 pylocytic astr
Publikováno v:
Medical Physics. 37:3457-3458
Magnetic resonance spectroscopy imaging(MRSI) provides completely non‐invasively detailed metabolic information which correlates with physiological or pathological conditions. Hence it is becoming a valuable tool in image guided radio(proton)therap